Sunday, December 21, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Stocks

T Rowe Price Stock: Mixed Earnings Reveal Deeper Struggles

Robert Sasse by Robert Sasse
August 1, 2025
in Stocks
0
T Rowe Price Stock
0
SHARES
4
VIEWS
Share on FacebookShare on Twitter

T. Rowe Price reported mixed second-quarter results, beating earnings expectations with $2.24 per share versus forecasts of $2.13 but missing revenue targets at $1.72 billion, a 0.6% year-over-year decline. The asset manager faced persistent outflows of $14.9 billion, particularly in equity funds ($18.1 billion), though multi-asset strategies saw modest inflows ($0.9 billion). Despite net client withdrawals, assets under management rose 6.9% to $1.68 trillion, driven by $125.4 billion in market gains. However, rising costs (up 6.5% to $1.25 billion) squeezed operating income, which plummeted 15.3% to $478.3 million, while fee margins eroded from 41.1 to 39.6 basis points.

ETFs Offer Limited Relief

The ETF division emerged as a bright spot, attracting $6.7 billion in inflows and growing assets to $16.2 billion, with 11 funds surpassing $500 million. Yet, this segment remains too small to offset broader challenges. Only 35% of U.S. funds outperformed peers over one year, and just 22% beat passive strategies. The stock dipped 0.44% premarket, reflecting investor skepticism about the firm’s ability to counter industry fee pressures and shifting client preferences.

Ad

T Rowe Price Stock: Buy or Sell?! New T Rowe Price Analysis from December 21 delivers the answer:

The latest T Rowe Price figures speak for themselves: Urgent action needed for T Rowe Price investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from December 21.

T Rowe Price: Buy or sell? Read more here...

Tags: T Rowe Price
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Eli Lilly Stock
Stocks

Eli Lilly’s Strategic Diversification Amid Weight-Loss Drug Competition

November 18, 2025
Micron Stock
Stocks

Micron Shares Approach Peak: What Comes After the AI Rally?

November 18, 2025
Varonis Stock
Stocks

Varonis Shares Plunge Amidst Mixed Signals

November 18, 2025
Next Post
Adobe Stock

Adobe Stock: Regulatory Blockade Backfires Spectacularly

Rackspace Technology Stock

Rackspace Technology Stock: Climate Goals Boost Competitive Edge

Strategy Stock

Strategy Stock: Bitcoin Bet Fuels Stunning Turnaround

Recommended

Vulcan Energy Stock

Vulcan Energy Shares Surge on Major Contract Breakthrough

4 months ago
SCHW stock news

Short Interest in Cantaloupe, Inc. (NASDAQ: CTLP) Raises Concerns Among Investors

3 years ago
Coty Stock

CEO’s Million-Dollar Bet Signals Potential Turning Point for Coty

4 months ago
MSCI World ETF Stock

The Hidden Concentration Risk in a Popular Global ETF

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin ASML BioNTech Bitcoin Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Strategy Inc. Faces a Critical Index Classification Decision

DeFi Technologies Broadens Global Reach with New Listings and Products

Barrick Gold Secures Key Resolution in Mali, Paving Way for Mine Restart

Analyst Upgrade Sends Red Cat Shares Soaring

A Billion-Dollar Vote of Confidence for Standard Lithium

UnitedHealth’s Battle to Regain Investor Confidence

Trending

Wolfspeed Stock
Analysis

Wolfspeed Secures Financial and Strategic Milestones

by Andreas Sommer
December 21, 2025
0

Following a period of significant volatility, shares of semiconductor specialist Wolfspeed have shown initial signs of stabilization...

Textron Stock

Textron Stock Approaches Annual Peak Amid Strategic Wins

December 21, 2025
Intellia Therapeutics Stock

Intellia Therapeutics Faces Mounting Analyst Scrutiny Amid Regulatory Setback

December 21, 2025
Strategy Stock

Strategy Inc. Faces a Critical Index Classification Decision

December 21, 2025
DeFi Technologies Stock

DeFi Technologies Broadens Global Reach with New Listings and Products

December 21, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Wolfspeed Secures Financial and Strategic Milestones
  • Textron Stock Approaches Annual Peak Amid Strategic Wins
  • Intellia Therapeutics Faces Mounting Analyst Scrutiny Amid Regulatory Setback

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com